stella
beta
Impact of Sulphonylureas on Neurodevelopmental Outcomes in KCNJ11-related Intermediate Developmental Delay, Epilepsy and Neonatal Diabetes (iDEND) Syndrome — Stella
Recruiting
Back to Neurodevelopmental Disorders trials
Trial locations
(4 sites)
United States
University of Chicago, Chicago, Illinois
Italy
University of Rome, Rome
Norway
University of Bergen, Bergen
United Kingdom
University of Exeter, Exeter
View full record on ClinicalTrials.gov